196

7th European Aniridia Conference
Venice 2014

7th European Aniridia Conference
Venice 2014

Datum
31.05.2024, 10:00 - 02.06.2024, 14:00
Kongress
Stockholm
Sprache
Englisch
Gebühren ab
500.00 SEK
Veranstalter
Aniridia Europe
Organisator

Aniridia Europe
Laskenveien 79 A
3214 Sandefjord
Contact: Chair Mr. Neven Milivojevic
Tel.: +46 70 639 0068


The European Aniridia Conference is a biannual conference that brings together researchers, practitioners and diagnosis carriers to share the latest scientific know-how, experiences and ideas about the rare genetic condition aniridia and aniridia-related diseases. Aniridia Sweden together with Linköping University and Aniridia Europe are proud to announce the 7th European Aniridia Conference (EAC) that will take place in Stockholm, Sweden on May 31st – June 2nd, 2024.
  • Basisinformation
    Datum
    31.05.2024, 10:00 - 02.06.2024, 14:00
    Kongress
    Stockholm
    Sprache
    Englisch
    Gebühren ab
    500.00 SEK
    Veranstalter
    Aniridia Europe
    Organisator

    Aniridia Europe
    Laskenveien 79 A
    3214 Sandefjord
    Contact: Chair Mr. Neven Milivojevic
    Tel.: +46 70 639 0068


  • VERANSTALTUNGSORT
    Blique by Nobis
    Gävlegatan 18
    113 30 Stockholm, SE
  • Programm

    Friday, 31 May

    10.00

    Registration opens

    12.00-13.00

    Lunch
    13.00 – 13.30

    Opening ceremony, welcome and introduction

    Prof. Neil Lagali, PhD, Linköping university, Sweden;
    Berit Byström, MD PhD, University Hospital of Umeå, Sweden;
    Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden;
    Barbara Poli, President of Aniridia Europe;
    Ivana Kildsgaard, President of Aniridia Sweden;
    Sten Kjellström, MD, PhD, CEO, S:t Erik eye hospital, Sweden

    13.30 – 14.00
    Opening keynote lecture
    “Dry eye disease – myths and facts”,
    Prof. Tor Paaske Utheim, Oslo university hospital, Norway
    14.00 – 15.00
    Session: Glaucoma and aniridia
    Chairs: Erlend Christoffer Sommer Landsend & Dominique Bremond-Gignac
    “Glaucoma in congenital aniridia. Clinical Considerations and Management”,
    Amelie Botling Taube, MD, PhD, S:t Erik eye hospital, Sweden;
    “Surgical management of aniridic glaucoma”,
    Prof. Peter A. Netland, MD, PhD, University of Virginia School of Medicine, USA
    15.00 – 15.30
    Coffee break
    15.30 – 17.00
    Session: New research areas in aniridia
    Chairs: Peter Netland & Tor Paaske Utheim
    “Aniridia and the brain”,
    Prof. James Lauderdale, PhD, University of Georgia, USA;
    “Health-related quality of life in congenital aniridia”,
    Erlend Christoffer Sommer Landsend, MD, PhD, Oslo university hospital, Norway;
    “Aniridia stories: Investigating congenital aniridia through narrative medicine”,
    Chiara Ancona, MD, University of Brescia, Italy;
    “Subjective symptoms and social consequences for patients with aniridia: Results of the pan-European COST survey study”,
    Renata Schoffer, MD, Region Östergötland, Sweden
    17.00 – 17.30
    Panel discussion: Aniridia as a syndrome or spectrum? Hinders and barriers for cross-European clinical management guidelines
    Moderator: James Lauderdale
    Participants: Peter Netland, Dominique Bremond-Gignac, Erlend Christoffer Sommer Landsend & Sophie Valleix

    18.45

    Meet-up and check-in at Stockholm City Hall inner yard – Address: Hantverkargatan 1

    19.00

    Reception and buffet dinner at Stockholm City Hall, hosted by the City of Stockholm and the Region of Stockholm

    Saturday, 1 June

    08.30 – 09.30

    Session: Artificial iris, cataract, posterior segment
    Chair: Bogumil Wowra
    “Artificial iris in aniridia: A dilemma”,
    Prof. Vito Romano, University of Brescia, Italy;
    “Posterior segment anomalies in PAX6-related congenital aniridia”,
    Prof. Dominique Bremond-Gignac, MD, PhD, FEBO, University hospital Necker enfants malades, APHP, France

    09.30 – 10.30

    Session: Keratopathy in aniridia
    Chairs: Christina Grupcheva & Miriam Barbany Rodríguez
    “Keratopathy in aniridia, clinical features and treatment options”,
    Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden
    & Per Montan, MD, PhD, S:t Erik eye hospital, Sweden;
    “Lessons learned from a Swedish register study of aniridia”,
    Berit Byström, MD, PhD, Umeå University, Sweden
    & Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden;
    “Outcomes of Corneal Transplantation to Treat Aniridia-Associated Keratopathy: Long Term Outcomes from UK Transplant Registry”,
    Prof. Francisco Figueiredo, Newcastle university, United Kingdom
    10.30 – 11.00Coffee break

    11.00 – 12.00

    Session: Stem cells and aniridia
    Chairs: Stefano Ferrari & Francisco Figueiredo
    “Molecular insights into aniridia-associated keratopathy”,
    Berit Byström, MD, PhD, Umeå University, Sweden;
    “Multi-omics analysis of aniridia stem cell-derived cornea cells”,
    Dulce Lima Cunha, PhD, Radboud university, the Netherlands;
    “Pluripotent stem cells as tools to study and treat limbal stem cell deficiency”,
    Adj. Prof. Tanja Ilmarinen, PhD, Tampere university, Finland

    12.00 – 13.30

    Lunch and poster rapid fire presentations

    13.30 – 14.30

    Session: Genetics and aniridia
    Chairs: Dominique Bremond-Gignac & James Lauderdale
    “Genetic diagnosis, clinical implications and patient management”,
    Prof. Mariya Moosajee, PhD, UCL institute of ophthalmololgy & the Francis Crick institute, United Kingdom;
    “NGS, WGS, optical mapping, and Hi-C tools to solve and interpret pathogenic mechanisms of congenital iris malformations: French experience from a cohort of more than 300 families”,
    Prof. Sophie Valleix, University hospital Necker enfants malades, France;
    “Syndromic aniridia and metabolomics”,
    Prof. Mariya Moosajee, PhD, UCL institute of ophthalmology & the Francis Crick institute, United Kingdom

    14.30 – 15.00

    Panel discussion: Challenges with genetic diagnosis, genotype-phenotype, and gene therapy; patient Q & A session
    Moderator: Peter Netland
    Participants: Neil Lagali, Mary Moosajee, Sophie Valleix & James Lauderdale

    15.00 – 15.30

    Coffee break

    15.30 – 17.00

    Session: Management of anirida and challenges for children
    Chairs: Laura Mauring & Bogumil Wowra
    “Management of infants and children with aniridia at a German national referral center”,
    Prof. Barbara Käsmann-Kellner, MD, PhD, Saarland university, Germany;
    “Corneal aspects of congenital aniridia”,
    Fabian Fries, MD, Saarland university medical center, Germany;
    “Management of aniridia – European guidelines”,
    Prof. Dominique Bremond-Gignac, MD, PhD, FEBO, University hospital Necker enfants malades, APHP, France;
    “Cohort data from 319 subjects with congenital aniridia at the Schwiete Center”,
    Prof. Nóra Szentmáry, PhD, Saarland university medical center, Germany

    17.00 – 17.30

    Panel discussion: Differences and similarities in management of aniridia in children
    Moderator: Bogumil Wowra
    Participants: Dominique Bremond-Gignac, Erlend Christoffer Sommer Landsend, Laura Meuring & Barbara Käsmann-Kellner

    19.00

    Dinner at the hotel restaurant

    Sunday, 2 June

    08.30 – 10.30

    Session: New therapies
    Chairs: Neil Lagali & Stefano Ferrari
    “Gene therapy approaches for aniridia”,
    Prof. Elizabeth M. Simpson, PhD, University of British Columbia, Canada;
    “Dynamic and customized iris embedded inside a scleral lens for aniridia patients”,
    Andrés Vásquez Quintero, PhD, Azalea Vision, Belgium;
    “Innovations in sutureless transplantation of amniotic membrane for the outpatient management of ocular surface diseases”,
    Ass. Prof. Andrew Hopkinson, PhD, University of Nottingham, United Kingdom;
    “Updates on eyedrop therapy for mouse models of aniridia-associated keratopathy”,
    Karina Hadrian, PhD, University Hospital of Cologne, Germany;
    “129S1/Svlmj Pax6 small-eye mice: A novel model for investigating innovative Aniridia Associated Keratopathy (AAK) therapies”,
    Dina Javidjam, PhD candidate, Linköping university, Sweden

    10.30 – 11.00

    Panel discussion: Spinning up the wheel for new therapies, challenges and potentials
    Moderators: James Lauderdale & Stefano Ferrari
    Participants: Elizabeth M. Simpson, Andrés Vásquez Quintero, Andrew Hopkinson, Martin Collins, Karina Hadrian & Dina Javidjam

    11.00 – 11.30

    Coffee break

    11.30 – 12.00

    Q & A session for patients and experts

    12.00 – 12.15

    Popular summary for patients and associations
    Prof. Neil Lagali, PhD, Linköping university, Sweden

    12.15 – 12.30

    Closing ceremony
    Branka Samolov, MD, PhD, S:t Erik eye hospital, Sweden;
    Berit Byström, MD, PhD, Umeå university, Sweden;
    Prof. Neil Lagali, PhD, Linköping university, Sweden;
    Neven Milivojevic, Vice President of Aniridia Sweden;
    Ivana Kildsgaard, President of Aniridia Sweden.
    Barbara Poli, President of Aniridia Europe.

    12.30

    Farewell lunch at the hotel restaurant

    14:00

    End of the conference

     

     

  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    2.500,00 SEK
    Studenten/-innen
    Gebühren ab
    500,00 SEK
  • Buchung / Anmeldung

    Contact the organizer for further information

  • Zertifizierung
    Zertifizierung unbekannt

Veranstaltung teilen